OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)
NCT00097422
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Diarrhea
Interventions
DRUG:
OPT-80
Sponsor
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)